Skip to main content
Top
Published in: Reactions Weekly 1/2024

01-03-2024 | Erythema Exsudativum Multiforme | Case report

Colchicine/lenalidomide/thalidomide

Lack of efficacy

Published in: Reactions Weekly | Issue 1/2024

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Weill A, et al. Erythema multiforme associated with anti-plakin antibodies: a multicentric retrospective case series. Journal of the European Academy of Dermatology and Venereology 36 : 2438-2442, No. 12, Dec 2022. Available from: URL: 10.1111/jdv.18259 Weill A, et al. Erythema multiforme associated with anti-plakin antibodies: a multicentric retrospective case series. Journal of the European Academy of Dermatology and Venereology 36 : 2438-2442, No. 12, Dec 2022. Available from: URL: 10.1111/jdv.18259
Metadata
Title
Colchicine/lenalidomide/thalidomide
Lack of efficacy
Publication date
01-03-2024
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2024
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-54812-x

Other articles of this Issue 1/2024

Reactions Weekly 1/2024 Go to the issue

Case report

Multiple drugs

Case report

Nivolumab

Case report

Bleomycin

Case report

Multiple drugs